BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be participating in the following investor conferences.
- Evercore ISI HealthCONx Virtual Conference; Fireside Chat on Tuesday, November 29 at 2:15pm EST / 8:15pm CET
- Credit Suisse 26th Annual Technology Conference in Scottsdale, AZ; Fireside Chat on Wednesday, November 30 at 1:40pm MST / 9:40pm CET
Interested parties may access live and archived webcasts of the sessions on the Investor Relations section of the company website at ir.sophiagenetics.com.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.
Investor Contact:
Jennifer Pottage
Head of Investor Relations
ir@sophiagenetics.com
Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
media@sophiagenetics.com
